Cabaletta Bio (CABA) Cash & Current Investments (2018 - 2026)
Cabaletta Bio (CABA) posted Cash & Current Investments of $225.1 million for Q2 2026, up 15.6% from $194.68 million a year earlier.
Powered by 
Analysis
Cabaletta Bio (CABA) Cash & Current Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, Cabaletta Bio's Cash & Current Investments came in at $133.6 million, down 18.5% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of 4.2% (FY2020 to FY2025).
- In prior years, Cabaletta Bio's Cash & Current Investments was $163.96 million in FY2024 (-32.0%), $241.25 million in FY2023 (+126.4%), $106.55 million in FY2022 (-12.8%) and $122.22 million in FY2021 (+12.5%).
- The Q2 2026 figure stands as the highest quarterly Cash & Current Investments since Q4 2023.
- On a year-over-year basis, Cash & Current Investments increased in two of the last seven quarters, with an average decline of 11.6%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q1 2024, with growth of 138.5%; the weakest was Q1 2025, with a decline of 41.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Cabaletta Bio | 249.23 Mn | 24.13 Mn | - | 225.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 225.10 Mn |
| Dec 31, 2025 | 133.60 Mn |
| Sep 30, 2025 | 159.93 Mn |
| Jun 30, 2025 | 194.68 Mn |
| Mar 31, 2025 | 131.83 Mn |
| Dec 31, 2024 | 163.96 Mn |
| Sep 30, 2024 | 183.01 Mn |
| Jun 30, 2024 | 203.23 Mn |
| Mar 31, 2024 | 223.85 Mn |
| Dec 31, 2023 | 241.25 Mn |
| Sep 30, 2023 | 164.39 Mn |
| Jun 30, 2023 | 176.33 Mn |
| Mar 31, 2023 | 93.85 Mn |
| Dec 31, 2022 | 106.55 Mn |
| Sep 30, 2022 | 85.90 Mn |
| Jun 30, 2022 | 96.81 Mn |
| Mar 31, 2022 | 109.21 Mn |
| Dec 31, 2021 | 122.22 Mn |
| Sep 30, 2021 | 119.26 Mn |
| Jun 30, 2021 | 102.81 Mn |
API Access
Cabaletta Bio Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CABA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "CABA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CABA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();